DUBAI, UAE, July 30, 2025 /PRNewswire/ -- The Healthcare Information and Management Systems Society (HIMSS) will deliver world-class content, professional development and roadmaps for digital health...
Fred LeBlanc of legendary New Orleans band, Cowboy Mouth first guest
NASHVILLE, Tenn., July 29, 2025 /PRNewswire/ -- On Wednesday, July 23rd, singer, songwriter, and...
SINGAPORE, July 29, 2025 /PRNewswire/ -- Singapore's vibrant CBD culinary scene welcomes a fresh perspective with the opening of American Mass Hall, a new dining...
LAS VEGAS, July 28, 2025 /PRNewswire/ -- PokerGO® and PokerStars® today announced the long-awaited return of the legendary National Heads-Up Poker Championship presented by PokerStars,...
Special streaming premiere of performance featuring the Carnegie Hall Big Band, filmed on tour at Segerstrom Center for the Arts, available for the first...
TREVOSE, Pa., July 25, 2025 /PRNewswire/ -- The Advertising Specialty Institute® (ASI), the leading authority in the $26.6 billion promotional products industry, today announced...
Le groupe Unimot envisage de se lancer dans l’industrie de la défense en investissant dans la nouvelle société PZL Defence, qui se spécialisera dans le développement et la production de drones et de systèmes anti-drones. Le projet sera réalisé en coopération avec PZL Sędziszów, un fabricant expert en composants pour l’industrie de la défense, et un partenaire ukrainien disposant d’une expertise pratique acquise en temps de guerre.
Le groupe Unimot envisage de se lancer dans l’industrie de la défense en investissant dans la nouvelle société PZL Defence, qui se spécialisera dans le développement et la production de drones et de systèmes anti-drones. Le projet sera réalisé en coopération avec PZL Sędziszów, un fabricant expert en composants pour l’industrie de la défense, et un partenaire ukrainien disposant d’une expertise pratique acquise en temps de guerre.
COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year clinical efficacy data from its phase 2 trial with lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2025 to be held in Berlin, Germany, from October 17-21, 2025.
BEIJING, July 24, 2025 /PRNewswire/ -- Life has never been happier for Xu Furong.
The 86-year-old resident of Nanliuzhuang village starts each morning with a bit of...
Spearheaded by Pacifica Christian High School's SurfersWhoServe, dozens of students will gather July 29 to advocate for continued leadership in ocean safety and environmental...